Search This Blog

Lung Cancer

Biocartis partners with AstraZeneca on lung cancer diagnostics - KFGO News

Get link
Facebook
X
Pinterest
Email
Other Apps

- November 29, 2018

Lung Cancer

Get link
Facebook
X
Pinterest
Email
Other Apps

Comments

Beagles, other dogs could be used to help in early detection of lung cancers, study finds - Fox 32 Chicago

- June 20, 2019

Beagles, other dogs could be used to help in early detection of lung cancers, study finds Fox 32 Chicago MYAKKA CITY, Fla - Dogs with a strong sense of smell, such as beagles, could help in early detection of certain lung cancers in humans, a recent study ...

Not An Ordinary Cough: Lung Cancer Symptoms That You Might Neglect - International Business Times

- January 07, 2020

Not An Ordinary Cough: Lung Cancer Symptoms That You Might Neglect International Business Times

Beagles, other dogs could be used to help in early detection of lung cancers, study finds - Fox 32 Chicago

- June 20, 2019

Beagles, other dogs could be used to help in early detection of lung cancers, study finds Fox 32 Chicago A recent study suggests that dogs with a strong sense of smell could help detect certain lung cancers early.

Powered by Blogger

Theme images by sandoclr

Genetic variations in the PI3K-PTEN-AKT-mTOR pathway are associated with distant metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy

- November 04, 2024

tnm staging non small cell carcinoma :: Article Creator What Is Non-Small-Cell Lung Cancer? About 80% of people who have lung cancer have non-small-cell lung cancer. NSCLC usually spreads more slowly than small-cell lung cancers. Both cancers affect the lungs and have similar symptoms, but they're treated differently. Types There are three main categories of NSCLC: Adenocarcinoma: This is the most common type. It usually spreads more slowly than others, and it's more likely to be found earlier. It's often linked to a history of smoking, but it is also the most common type of lung cancer seen in nonsmokers. It starts in the cells that make mucus, and it's usually found in the outer parts of your lung. Squamous cell (epidermoid) carcinoma: This starts in the lining of the airways in the lungs. About a quarter of all lung cancers are this type. It's often linked to a history of smoking. Large-cell (undifferentiated) car...

Endocrine regulation and metabolic mechanisms of osteopontin in the development and progression of osteosarcoma, metastasis and prognosis

- December 18, 2024

extensive small cell carcinoma :: Article Creator FDA Grants Breakthrough Therapy Status To Gilead's Trodelvy For Treatment Of Small Cell Lung Cancer (RTTNews) - Gilead Sciences, Inc. (GILD) Tuesday said that the U.S. Food and Drug Administration or FDA has granted Breakthrough Therapy Designation to Trodelvy for the treatment of adults with extensive-stage small cell lung cancer (ES-SCLC). The Breakthrough Therapy Designation is based on encouraging results from the Phase 2 TROPiCS-03 study of Trodelvy as a second-line treatment for ES-SCLC. Trodelvy is currently approved in more than 40 countries for multiple types of breast cancer. The drug is also approved for the treatment of urothelial cancer in many countries. Small Cell Lung Cancer: Navigating The Global Clinical Trial Landscape Small cell lung cancer is a fast-growing and aggressive subtype of lung cancer, accounting for approximately 10-15% of all lung cancer cases globally. ...

Drug-Induced Lung Disease Imaging: Practice Essentials, Radiography, Computed Tomography

- December 12, 2024

secondary lung cancer stages :: Article Creator This Remarkable MSK Patient Is Living With Two Kinds Of Stage 4 Cancer To see Michael Simien darting in and out of New York City streets on his bike, you'd never guess he is 70 years old — let alone that he is living with two kinds of metastatic cancer: lung cancer that was diagnosed 10 years ago and a rare, aggressive type of non-Hodgkin lymphoma called mantle cell lymphoma that was diagnosed five years ago. Michael is keenly aware that he has beaten the odds. When a persistent cough led him to the emergency room of another hospital, a physician told him in the waiting room his scans suggested he had lung cancer. "There goes a bone fide walking dead man," he heard another patient say as Michael left the ER, stunned. Michael wept and prayed, and then he got to work. His research led him to Memorial Sloan Kettering Cancer Center (MSK) for treatment, where he met with thoracic medical o...

Nine new cancers added to the presumed service-connected list related to particulate matter

- November 21, 2024

prognosis of pancreatic cancer :: Article Creator NHS Shares Two Pancreatic Cancer Symptoms That Can Show Up On The Skin Two signs may show up on the skin ( Image: Getty Images/Viktoriya Skorikova) The NHS wants people to be aware of the common symptoms of pancreatic cancer, referred to by some as a "silent killer". Pancreatic cancer is known as such because it is often difficult to detect until it has progressed, and it has the highest mortality rate of all cancers. Survival rates are poor, with just 25% of those who are diagnosed surviving more than a year. Only 5% live for ten years or more after being told they have pancreatic cancer. A new update on X, formerly Twitter, from the official NHS account reads: "Symptoms of pancreatic cancer can be caused by lots of things, which can make it hard to diagnose." "It's important to be checked by a GP if things don't feel normal for you, or if any ...

Sugar and cancer – what you need to know

- December 14, 2024

stage zero breast cancer :: Article Creator Breast Cancer Surgery Not Always Necessary, New Research Suggests A pair of studies suggest some patients with early-stage breast cancer may be able to safely avoid certain surgeries, adding to ongoing conversations about how aggressively to treat low-risk cancers. The research was presented Dec. 12 at the San Antonio Breast Cancer Symposium. One study involving 950 patients found women with ductal carcinoma in situ who were closely monitored were no more likely to develop invasive breast cancer than those who underwent surgery. Participants were randomly divided into two groups: one received the current standard of care — surgery with or without radiation — while the other followed active surveillance, which involved mammograms every six months. Those in the active monitoring group could opt for surgery at any time, and most women in both cohorts received hormone therapy to prevent cancer growth. A...

Pembrolizumab Monotherapy Demonstrates Clinical Efficacy in High ...

- June 27, 2023

stage 3 breast cancer survival rate by age :: Article Creator Huge Leap In Breast Cancer Survival Rate Mammograms can be used to diagnose breast cancer.Credit: Michael Hanschke/DPA Picture Alliance/Avalon The number of people who die after a breast cancer diagnosis has decreased by two-thirds since the 1990s, a study of more than half a million women in England has shown. The research has taken ten years to complete, says Carolyn Taylor, lead author of the study and an oncologist at the University of Oxford, UK. The analysis includes the 512,447 women in England who were diagnosed with early invasive breast cancer between January 1993 and December 2015; the researchers tracked the women until December 2020 using data from the National Cancer Registration and Analysis Service. Women who were diagnosed in 1993–99 had a 14.4% risk of dying within 5 years. This fell to 4.9% for women diagnosed in 2010–15 (see 'Improved odds'). The results we...

Second Malignancies after Radiation Therapy: Update on Pathogenesis and Cross-sectional Imaging Findings

- October 13, 2024

early stage skin breast cancer :: Article Creator Empowering Women Through Early Breast Cancer Detection: Taking Control Of Your Health For Breast Cancer Awareness Month, Deborah Toppmeyer, MD, emphasizes the crucial role of early breast cancer detection. As a physician specializing in breast oncology, I feel that one of the most important messages I can share with my patients, particularly women, is the importance of early breast cancer detection. Breast cancer accounts for about 1 in 3 female cancer diagnoses each year, making it the most common cancer among women worldwide. While this statistic might seem daunting, there is another side to the story—one of hope, empowerment, and improved outcomes.1 It is not just about finding the disease early; it is also about empowering women to take control of their health and well-being, potentially saving lives through timely interventions—especially as breast cancer diagnoses in women under 50 become m...

HTR2B as a novel biomarker of chronic obstructive pulmonary disease with lung squamous cell carcinoma

- December 02, 2024

types of primary lung cancer :: Article Creator Tiragolumab Plus Tecentriq Misses Survival Endpoint For Lung Cancer Subset The primary endpoint of overall survival was missed in the SKYSCRAPER-01 study assessing tiragolumab plus Tecentriq in some patients with non-small cell lung cancer. Genentech announced that a clinical trial of tiragolumab plus Tecentriq did not meet its primary endpoint of overall survival in patients with non-small cell lung cancer. The primary endpoint of overall survival was not met in the phase 3 SKYSCRAPER-01 study comparing tiragolumab plus Tecentriq (atezolizumab) with Tecentriq alone to treat PD-L1-high, locally advanced or metastatic non-small cell lung cancer. The announcement was made in a press release from Genentech, the manufacturer of tiragolumab. Tiragolumab, according to the release, is an immune checkpoint inhibitor that selectively binds to TIGIT, a novel inhibitory immune checkpoint that may ...

Oncologist In Senegal Recounts Experience Treating Patients With Lung Cancer - Kaiser Family Foundation

- May 31, 2019

Oncologist In Senegal Recounts Experience Treating Patients With Lung Cancer Kaiser Family Foundation CDC's “Our Global Voices”: Taking Back the Lives That Tobacco Use Cuts Short: One Story from a Physician in Senegal Oumar Ba, oncologist at Hôpital ...

Lung Cancer, Thoracic Oncology

- November 25, 2024

small cell carcinoma not in lungs :: Article Creator Why Is Small Cell Lung Cancer So Difficult To Treat? Small cell lung cancer (SCLC) is rarer than non-small cell lung cancer (NSCLC) but tends to be more difficult to treat. SCLC can be more resistant and aggressive than other cancers, which can increase the risk of relapses. Survival rates for many types of cancer have improved drastically over the last several decades. Despite this, SCLC survival rates have remained less favorable. From 2000 to 2016, the 5-year relative survival rate in the United States only improved from 6.0% to 8.7%. Most cases of SCLC have already spread to distant body parts when they're diagnosed. This is because SCLC is an aggressive cancer. Even though many people respond to initial treatment, the majority experience relapse. Researchers are still investigating why SCLC tends to be more resistant to treatment than most other cancers. ...

Labels

How do you detect lung cancer early
how to cure lung cancer at home
IFTTT
Lung Cancer
lung cancer causes
lung cancer stages
lung cancer symptoms
lung cancer treatment
metastatic lung cancer
signs of lung cancer

signs+of+lung+cancer
stage 4 lung cancer
symptoms of lung cancer in females
types of lung cancer
What are the first signs of lung cancer UK
what is lung cancer

Show more Show less

Search This Blog

Lung Cancer

Biocartis partners with AstraZeneca on lung cancer diagnostics - KFGO News

Comments

Post a Comment

Popular posts from this blog

Beagles, other dogs could be used to help in early detection of lung cancers, study finds - Fox 32 Chicago

Not An Ordinary Cough: Lung Cancer Symptoms That You Might Neglect - International Business Times

Beagles, other dogs could be used to help in early detection of lung cancers, study finds - Fox 32 Chicago